Pharvaris (PHVS) Receivables - Net (2019 - 2026)

Pharvaris posted quarterly Receivables - Net of $1.1 million for Q1 2026, up 75.16% on a QoQ basis from $648068.4 in Q4 2025.

Pharvaris (PHVS) has 8 years of Receivables - Net data on file, last reported at $1.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Receivables - Net changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (changed N/A YoY), and the FY2025 full-year result was $629010.0, down 80.26% from the prior year.
  • Receivables - Net for Q1 2026 stood at $1.1 million, up from $648068.4 in the prior quarter.
  • Across five years, Receivables - Net topped out at $3.1 million in Q4 2024 and bottomed at $390212.0 in Q4 2022.
  • The 5-year median for Receivables - Net is $1.1 million (2023), against an average of $1.3 million.
  • The widest annual swing landed in 2022, when Receivables - Net soared 3936.24%; it then plunged 79.4% in 2025.
  • A 5-year view of Receivables - Net shows it stood at $390212.0 in 2022, then surged by 186.49% to $1.1 million in 2023, then surged by 181.46% to $3.1 million in 2024, then slumped by 79.4% to $648068.4 in 2025, then jumped by 75.16% to $1.1 million in 2026.
  • The last three Receivables - Net figures came in at $1.1 million (Q1 2026), $648068.4 (Q4 2025), and $3.1 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Pharvaris 267.74 Mn -73.74 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.14 Mn
Mar 31, 2026 1.14 Mn
Dec 31, 2025 648,068.42
Dec 31, 2025 648,068.42
Dec 31, 2024 3.15 Mn
Dec 31, 2024 3.15 Mn
Dec 31, 2023 1.12 Mn
Dec 31, 2023 1.12 Mn
Dec 31, 2022 390,211.97
Dec 31, 2022 390,211.97
Dec 31, 2021 9,667.70
Dec 31, 2021 9,667.70
Dec 31, 2020 679,102.07
Dec 31, 2020 679,102.07
Dec 31, 2019 233,379.52
Dec 31, 2019 233,379.52